register

News & Trends - Pharmaceuticals

Medicines supply chain prepared for summer season challenges

Health Industry Hub | December 17, 2020 |

Pharma News: Increased collaboration and new investment in distribution logistics have provided additional certainty for the medicine supply chain in the event of seasonal disasters such as bushfires, floods and cyclones, according to the National Pharmaceutical Services Association (NPSA), representing full-line pharmaceutical wholesalers in Australia.

As summer temperatures rise and during a La Niña weather cycle, Australia’s medicine distribution network is on a ready footing should communities again be cut off or affected by spikes in medicine demands.

NPSA Chair Richard Vincent said “Throughout 2020 our member companies have demonstrated expertise in crisis situations with successful management of health logistics during the bushfires and COVID-19, both of which have placed extraordinary pressure on all supply chains. We have been able to use this experience to further enhance our capability and agility to service community pharmacy, patients and governments during challenging situations.

“Rapid response teams are ready to be activated across our distribution network along with disaster management strategies for our road transport teams. We understand that every disaster is different and presents our network with a unique set of challenges. Our members are well placed to respond and help manage spikes in demand and shortages in medicine supplies where possible, something which occurred in March and April this year as COVID panic buying took hold.

“The pandemic has provided fresh insights into consumer behaviour and contributed data which we are using to inform minute-by-minute decision making about high demand medicines.

“The bushfires caused a spike in dispensing for all respiratory medication and a recent Australian Institute of Health and Welfare (AIHW)i report highlighted an example of a sustained period of increased dispensing of salbutamol inhalers in the ACT with a 134 per cent increase as bushfires raged in the first week of the New Year.

“In March, NPSA members managed record volumes of medicines, moving 70% more product, including high care speciality drugs, into communities across metro, regional and remote areas. We took proactive measures to support equitable access during a highly challenging period.”

Recent combined investment of more than $650M by member companies has seen the opening of two new automated distribution centres in NSW and VIC, bringing online additional capacity of 60,000 sqm of storage.

Mr Vincent continued “Our thoughts are with everyone following the events of 2020. We want the community to know that the various segments of the medicines supply chain have never been more connected, from government, manufacturer, distributor, pharmacy and through to patient with increased information sharing and dialogue. NPSA is an active participant in the government’s medicines shortages working group and has secured a year-long ACCC authorisation allowing member companies to work together to manage the challenges of COVID-19.”

The National Pharmaceutical Services Association (NPSA) members are Australian Pharmaceutical Industries (API), NPD (National Pharmacies), Sigma Healthcare and Symbion.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.